rhGDF-5 Production via Fed-Batch Fermentation Media

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing recombinant human growth and differentiation factor-5 (rhGDF-5) face challenges in achieving cost-effectiveness, time-efficiency, and maintaining manufacturing quality due to issues like uncontrolled growth rates, waste product accumulation, and the complexity of large-scale biologic production processes.

Innovation Solution

The use of a T5 or Trc promoter in expression vector systems for rhGDF-5 production, combined with a high cell density fed-batch fermentation media containing sodium molybdate, magnesium sulfate heptahydrate, sodium chloride, EDTA, MOPS, amino acid, and vitamin supplements, to optimize protein expression and plasmid yield.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If high cell density fed-batch fermentation is used for rhGDF-5 production, then productivity and plasmid yield are improved, but process complexity and manufacturing precision requirements increase

Engineering Contradiction:
ImproverhGDF-5 production quantityVSAvoidfermentation process complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent optimizes specific parameters of the fermentation medium including sodium molybdate concentration (5-20 mg/L), magnesium sulfate heptahydrate (2-10 mM), sodium chloride (1-5 g/L), EDTA (10-100 μM), MOPS buffer pH (6.5-7.5), amino acid supplements (0.1-1 mM), and vitamin supplements (1-10 μM) to achieve high cell density while maintaining controllable process complexity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs fed-batch fermentation which inherently uses feedback control by monitoring cell density and nutrient consumption rates to adjust feed addition, thereby maximizing productivity while maintaining process control despite increased complexity

Inventive Principle:
Principle #23Feedback

2Quantity of substance

If fed-batch fermentation with growth rate restriction is used, then plasmid yield and protein expression are enhanced, but production time and process duration increase

Engineering Contradiction:
Improveplasmid yieldVSAvoidfermentation process time
Core Design Contradiction:
Quantity of substanceVSLoss of time

Solution Approach 1:

The patent uses periodic fed-batch fermentation where growth rate is restricted during early phases to accumulate plasmid, followed by induction phases for protein expression, creating a periodic cycle that maximizes both plasmid yield and protein production while managing overall process time

Inventive Principle:
Principle #19Periodic action

Solution Approach 2:

The patent performs preliminary growth rate restriction and nutrient limitation before induction to ensure high plasmid accumulation and cell density are achieved first, which then enables superior protein expression during subsequent phases, optimizing the sequence of events to balance time and yield

Inventive Principle:
Principle #10Preliminary action

3Manufacturing precision

If complex media supplements are added to optimize protein expression, then manufacturing quality and protein yield improve, but production cost increases

Engineering Contradiction:
Improveprotein expression qualityVSAvoidproduction cost
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent systematically optimizes the concentrations of media supplements including sodium molybdate (5-20 mg/L), magnesium sulfate heptahydrate (2-10 mM), sodium chloride (1-5 g/L), EDTA (10-100 μM), MOPS buffer (10-100 mM), amino acids (0.1-1 mM), and vitamins (1-10 μM) to achieve the lowest effective concentrations that still provide high-quality protein expression, thereby reducing cost while maintaining manufacturing precision

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent combines multiple supplements into a single integrated fed-batch fermentation medium formulation that works synergistically to improve protein expression quality without requiring each supplement to be present at high concentrations, thus reducing overall production cost while maintaining manufacturing precision

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the cost-effective and time-saving production of rhGDF-5 in large quantities with improved protein expression and plasmid yield, enhancing the manufacturing quality and efficiency of the biologic production process.

Implementation Method 1

an expression vector having a polynucleotide encoding an rhGDF-5 protein under the control of a T5 or Trc promoter

Methodology Applied
Scientific EffectPromoter-driven transcription: Enzyme

Implementation Method 2

high cell density fed-batch fermentation media containing sodium molybdate, magnesium sulfate heptahydrate, sodium chloride, EDTA, MOPS, amino acid, and vitamin supplements

Methodology Applied
Scientific EffectFermentation: Fermentation

Data Source

PatentUS9359417B2Cell cultures and methods of human recombinant growth and differentiaton factor-5 (rhGDF-5)
Publication Date: 2016.06.07 WARSAW ORTHOPEDIC INC

AI summary

A cell culture media for plasmid production is provided for increased production of a recombinant GDF-5 (rhGDF-5) protein. Also provided herein is a method of making a cell culture media for plasmid production and a method for growing a plasmid vector. The methods of enhancing production and protein expression of rhGDF-5 protein as disclosed are cost-effective, time-saving and are of manufacturing quality.